Zhuo Chen
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery 5
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 27
- MicroRNA in disease regulation 22
- Molecular Biology top 2%
- Circular RNAs in diseases 11
- RNA Research and Splicing 8
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 6
- Biomedical Engineering top 1%
- Pharmaceutical Science top 1%
-
- Diabetes and associated disorders 6
- Co-authors
- Dong M. ShinMark E. DavisRama NatarajanXiwei WuLinda LantingMarpadga A. ReddyMei WangLingxiao Zhang
- Journals
- Diabetes (3 papers)Nature Communications (3 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Zhuo Chen
73 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Biomaterials 2.4k
- Cancer Research 1.4k
- Molecular Biology 3.3k
- Biomedical Engineering 1.8k
- Pharmaceutical Science 241
Countries citing papers authored by Zhuo Chen
This map shows the geographic impact of Zhuo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuo Chen more than expected).
Fields of papers citing papers by Zhuo Chen
This network shows the impact of papers produced by Zhuo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuo Chen. The network helps show where Zhuo Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhuo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 11 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 11 | |
| 11 | 2020 | 66 | |
| 12 | 2020 | 26 | |
| 13 | 2018 | 105 | |
| 14 | 2017 | 84 | |
| 15 | 2016 | 1 | |
| 16 | 2014 | 201 | |
| 17 | 2013 | 99 | |
| 18 | 2013 | 34 | |
| 19 | Nanoparticle therapeutics: an emerging treatment modality for cancerbreakdown → | 2008 | 3539 |
| 20 | Synergistic tumor growth inhibition by combined treatment with green tea epigallocatechin-3-gallate (EGCG) and an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), erlotinib in squamous cell carcinoma of the head and neck (SCCHN) | 2006 | 7 |
About Zhuo Chen
Zhuo Chen is a scholar working on Cancer Research, Molecular Biology, Applied Microbiology and Biotechnology, Immunology and Biomaterials, having authored 80 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), MicroRNA in disease regulation (22 papers), Circular RNAs in diseases (11 papers), RNA Research and Splicing (8 papers), Epigenetics and DNA Methylation (7 papers), Diabetes and associated disorders (6 papers), RNA modifications and cancer (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). The work is most often cited by research in Biomaterials (2.4k citations), Cancer Research (1.4k citations), Molecular Biology (3.3k citations), Biomedical Engineering (1.8k citations) and Pharmaceutical Science (241 citations). Zhuo Chen has collaborated with scholars based in China, United States and India. Frequent co-authors include Dong M. Shin, Mark E. Davis, Rama Natarajan, Xiwei Wu, Linda Lanting, Marpadga A. Reddy, Mei Wang, Lingxiao Zhang, Miao Feng and Amy Leung. Their work appears in journals such as Diabetes, Nature Communications, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.